GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ArcticZymes Technologies ASA (FRA:B4V) » Definitions » Book Value per Share

ArcticZymes Technologies ASA (FRA:B4V) Book Value per Share : €0.53 (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is ArcticZymes Technologies ASA Book Value per Share?

ArcticZymes Technologies ASA's book value per share for the quarter that ended in Mar. 2024 was €0.53.

During the past 12 months, ArcticZymes Technologies ASA's average Book Value Per Share Growth Rate was 7.70% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 14.80% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 50.40% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 16.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of ArcticZymes Technologies ASA was 82.00% per year. The lowest was -44.70% per year. And the median was 13.20% per year.

ArcticZymes Technologies ASA's current price is €2.155. Its book value per share for the quarter that ended in Mar. 2024 was €0.53. Hence, today's PB Ratio of ArcticZymes Technologies ASA is 4.04.

During the past 13 years, the highest P/B Ratio of ArcticZymes Technologies ASA was 43.32. The lowest was 3.10. And the median was 6.71.

Good Sign:

ArcticZymes Technologies ASA stock PB Ratio (=4.15) is close to 5-year low of 3.81


ArcticZymes Technologies ASA Book Value per Share Historical Data

The historical data trend for ArcticZymes Technologies ASA's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ArcticZymes Technologies ASA Book Value per Share Chart

ArcticZymes Technologies ASA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Book Value per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.09 0.38 0.48 0.54 0.53

ArcticZymes Technologies ASA Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.51 0.50 0.53 0.53 0.53

Competitive Comparison of ArcticZymes Technologies ASA's Book Value per Share

For the Biotechnology subindustry, ArcticZymes Technologies ASA's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ArcticZymes Technologies ASA's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ArcticZymes Technologies ASA's PB Ratio distribution charts can be found below:

* The bar in red indicates where ArcticZymes Technologies ASA's PB Ratio falls into.



ArcticZymes Technologies ASA Book Value per Share Calculation

ArcticZymes Technologies ASA's Book Value Per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(26.89-0.00)/50.87
=0.53

ArcticZymes Technologies ASA's Book Value Per Share for the quarter that ended in Mar. 2024 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(27.19-0.00)/50.87
=0.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


ArcticZymes Technologies ASA  (FRA:B4V) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


ArcticZymes Technologies ASA Book Value per Share Related Terms

Thank you for viewing the detailed overview of ArcticZymes Technologies ASA's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


ArcticZymes Technologies ASA (FRA:B4V) Business Description

Traded in Other Exchanges
Address
Sykehusveien 23, Tromso, NOR, N-9294
ArcticZymes Technologies ASA is a biotechnology company. The company is engaged in developing, producing, and marketing immune-modulating beta-glucans and novel recombinant enzymes. The company's products include Woulgan wound gel, Feed Ingredient (M-Glucan), Nutraceuticals (M-Gard), Recombinant enzymes, and others. The company reports in two operating segments that are Enzymes and Corporate. Geographically, it derives a majority of revenue from the USA.

ArcticZymes Technologies ASA (FRA:B4V) Headlines

No Headlines